Výsledky vyhledávání - "Maureen, van den Donk"

Akademický článek

A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study

Autor: Rebecca K Simmons, Knut Borch-Johnsen, Torsten Lauritzen, Guy EHM Rutten, Annelli Sandbæk, Maureen van den Donk, James A Black, Libo Tao, Edward CF Wilson, Melanie J Davies, Kamlesh Khunti, Stephen J Sharp, Nicholas J Wareham, Simon J Griffin

Publikováno v: Health Technology Assessment, Vol 20, Iss 64 (2016)

Background: Intensive treatment (IT) of cardiovascular risk factors can halve mortality among people with established type 2 diabetes but the effects of treatment earlier in the disease trajectory are uncertain. Objective: To quantify the cost-effect

Externí odkaz: https://doaj.org/article/570517e2d50449fbbbd0fd13c37ca1b3

Zobrazit plný text záznamu

[Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors]

Autor: Arianne F E, Verburg, Maureen, van den Donk, Tjerk, Wiersma

Publikováno v: Nederlands tijdschrift voor geneeskunde. 163

A comprehensive review of the literature on DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors has resulted in small changes to the medication roadmap of the type 2 diabetes mellitus standard of the Dutch College of General Practitioners

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ea4d109cf75e1bb41ad8641962bdac61
https://pubmed.ncbi.nlm.nih.gov/30676706

Zobrazit plný text záznamu

Cumarinederivaten en DOAC’s voortaan gelijkwaardig

Autor: Tjerk Wiersma, Jip de Jong, Geert-Jan Geersing, Maureen van den Donk

Publikováno v: Huisarts en wetenschap. 59:406-409

In Nederland zijn sinds enige jaren directe orale anticoagulantia op de markt (DOAC’s, ook wel nieuwe of ‘niet-vitamine K-antagonist orale anticoagulantia’ (NOAC’s) genoemd). Deze middelen worden onder andere gebruikt ter preventie van trombo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b61e547cf28a2f1f48dbcd8eb99adae0
https://doi.org/10.1007/s12445-016-0243-5

Zobrazit plný text záznamu

Herziene NHG-Standaard Urineweginfecties

Autor: Margriet Bouma, Maureen van den Donk, Tamara N Platteel

Publikováno v: Huisarts en wetenschap. 63:60-60

De NHG-Standaard Urineweginfecties is herzien. In deze herziening is de indeling van urineweginfecties gewijzigd. Daarnaast is het diagnostische stroomschema vereenvoudigd. Ook is vanwege antibioticaresistentie en bijwerkingen het medicamenteus belei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::039b9239ccc596629a79a4e6d9962524
https://doi.org/10.1007/s12445-020-0584-y

Zobrazit plný text záznamu

Herziening NHG-Standaard Stabiele angina pectoris

Autor: Margriet Bouma, Maureen van den Donk, Masja Loogman

Publikováno v: Huisarts en wetenschap. 63:54-55

De NHG-Standaard Stabiele angina pectoris is herzien. Het inspannings-ecg wordt niet meer aanbevolen voor de diagnostiek van angina pectoris. Ook zijn het medicamenteuze beleid en het verwijsbeleid aangepast.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30e6e0eb35935b578dfc7cfc651bc5ac
https://doi.org/10.1007/s12445-019-0396-0

Zobrazit plný text záznamu

New oral anticoagulants for nonvalvular atrial fibrillation in the elderly: Limited applicability in primary care

Autor: Ton Kuijpers, Maureen van den Donk, Wim Opstelten, Jako S. Burgers

Publikováno v: European Journal of General Practice. 21:1-5

Based on the results from randomized controlled trials (RCTs), new oral anticoagulants (NOACs) seem attractive alternatives to vitamin K antagonists (VKAs) because of their effectiveness, safety, and ease of use. However, the use of NOACs in unselect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b663902c5b133ad00983d36750a4ba7c
https://doi.org/10.3109/13814788.2014.989986

Zobrazit plný text záznamu

Effect of Early Multifactorial Therapy Compared With Routine Care on Microvascular Outcomes at 5 Years in People With Screen-Detected Diabetes: A Randomized Controlled Trial

Autor: Annelli Sandbæk, Stephen J. Sharp, Rebecca K. Simmons, Torsten Lauritzen, Nicholas J. Wareham, Kamlesh Khunti, Knut Borch-Johnsen, Melanie J. Davies, Maureen van den Donk, Guy E.H.M. Rutten, Simon J. Griffin

Publikováno v: Diabetes Care. 37:2015-2023

OBJECTIVE To determine the benefit of multifactorial treatment on microvascular complications among people with type 2 diabetes detected by screening. RESEARCH DESIGN AND METHODS This study was a multicenter cluster randomized controlled trial in pri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e7f08c0e5016ae6ca21eacb2e52f0b8
https://doi.org/10.2337/dc13-1544

Zobrazit plný text záznamu

Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?

Autor: Annelli Sandbæk, Maureen van den Donk, Nicholas J. Wareham, Rebecca K. Simmons, Kamlesh Khunti, Knut Borch-Johnsen, Melanie J. Davies, Torsten Lauritzen, Guy E.H.M. Rutten, Simon J. Griffin

Publikováno v: Diabetes Management. 3:367-378

SUMMARY The main ADDITION study was planned as a screening study followed by a randomized, intervention study comparing routine treatment with more intensive treatment in people with screen-detected diabetes. The stepwise screening programs had low y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9acfdc9c359005db3874feed247269e4
https://doi.org/10.2217/dmt.13.40

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání